Research programme: KGF receptor agonist - AffymaxAlternative Names: Keratide; Keratinocyte growth factor receptor agonist - Affymax; KGF receptor agonist research programme - Affymax
Latest Information Update: 27 Aug 2009
At a glance
- Originator Affymax
- Mechanism of Action Intercellular signalling peptide and protein stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Bone marrow transplant rejection; Cancer; Mucositis
Most Recent Events
- 10 May 2005 Early research in Cancer in USA (unspecified route)
- 10 May 2005 Early research in Mucositis in USA (unspecified route)
- 10 May 2005 Early research in Bone marrow transplant rejection in USA (unspecified route)